Search

Your search keyword '"Lindesmith, Lisa C"' showing total 246 results

Search Constraints

Start Over You searched for: Author "Lindesmith, Lisa C" Remove constraint Author: "Lindesmith, Lisa C"
246 results on '"Lindesmith, Lisa C"'

Search Results

1. Emergence of Novel Norovirus GII.4 Variant

2. Norovirus

3. Contributors

9. Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters

14. Progress in vaccine development for infectious diseases—a Keystone Symposia report

15. Contributors

16. Norovirus Vaccines

17. Immune Imprinting Drives Human Norovirus Potential for Global Spread

18. Chapter 43 - Norovirus

19. Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody Immunity

21. Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young Children

25. Antigenic Site Immunodominance Redirection Following Repeat Variant Exposure

26. Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum

28. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice

29. Predicted Norovirus Resurgence in 2021-2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study

30. Additional file 4 of Predicted norovirus resurgence in 2021���2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study

31. Additional file 3 of Predicted norovirus resurgence in 2021���2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study

32. Additional file 2 of Predicted norovirus resurgence in 2021���2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study

33. Additional file 1 of Predicted norovirus resurgence in 2021���2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study

34. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques

35. Secretor Status Strongly Influences the Incidence of Symptomatic Norovirus Infection in a Genotype-Dependent Manner in a Nicaraguan Birth Cohort

37. Chimeric spike mRNA vaccines protect against Sarbecoviruschallenge in mice

38. Mechanisms of GII.4 norovirus persistence in human populations

39. Secretor Status Strongly Influences the Incidence of Symptomatic Norovirus Infection in a Genotype-Dependent Manner in a Nicaraguan Birth Cohort.

42. CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus

43. CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus

45. Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study.

47. 42 - Norovirus Vaccines

48. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial

Catalog

Books, media, physical & digital resources